MedTrace Logo

Measurement Of NT-proBNP to Predict Outcomes in Surgery

NCT04014647 · Status: SUSPENDED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2023-12-22

No results posted yet for this study

Summary

The team is investigating whether N-terminal pro B-type natriuretic peptide (NT-proBNP) and other cardiac markers are useful for predicting outcomes for patients undergoing vascular surgery. By measuring NT-proBNP before and after surgery, the investigators may be able to determine which patients are at risk of an adverse outcome, such as a heart attack or death.

Conditions

  • Vascular Surgical Procedure

Sponsors & Collaborators

  • Julie Dawson

    lead OTHER

Principal Investigators

  • Emma Miler, MSc BSc Hons · principle investigator

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-05
Primary Completion
2025-09-01
Completion
2025-09-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04014647 on ClinicalTrials.gov